Related Experiment Video

Updated: Aug 4, 2025

A Platform of Anti-biofilm Assays Suited to the Exploration of Natural Compound Libraries
09:39

A Platform of Anti-biofilm Assays Suited to the Exploration of Natural Compound Libraries

Published on: December 27, 2016

17.8K

A structure activity relationship study of 3,4'-dimethoxyflavone for ArlRS inhibition in Staphylococcus aureus

Alexander W Weig1, Patrick M O'Conner1, Jakub M Kwiecinski2

  • 1Department of Chemistry and Biochemistry, University of Notre Dame, Notre Dame, IN 46556, USA. cmelande@nd.edu.

Organic & Biomolecular Chemistry
|April 4, 2023
PubMed

Insights

Researchers explored flavone compounds to inhibit the ArlRS two-component system (TCS) in methicillin-resistant Staphylococcus aureus (MRSA). They identified compounds with enhanced activity and one that suppresses oxacillin resistance, offering new therapeutic strategies.

Area of Science:

  • Microbiology
  • Drug Discovery
  • Molecular Biology

Background:

  • Methicillin-resistant Staphylococcus aureus (MRSA) presents significant treatment challenges due to antibiotic resistance and coordinated virulence factor expression.
  • Two-component systems (TCS), such as ArlRS, are crucial for MRSA's adaptation to environmental stimuli and virulence regulation.
  • 3,4'-dimethoxyflavone was previously identified as a selective inhibitor of the ArlRS TCS.

Purpose of the Study:

  • To investigate the structure-activity relationship (SAR) of the flavone scaffold for ArlRS inhibition.
  • To identify novel flavone derivatives with improved ArlRS inhibitory activity.
  • To discover compounds that can suppress antibiotic resistance in MRSA and elucidate their mechanism of action.

Main Methods:

  • Systematic modification of the flavone scaffold to generate a library of derivatives.
  • In vitro assays to evaluate ArlRS inhibitory activity and SAR.
  • Assessment of compound efficacy in suppressing oxacillin resistance in MRSA.
  • Preliminary mechanistic studies to understand the mode of action.

Main Results:

  • Several flavone derivatives demonstrated enhanced ArlRS inhibitory activity compared to 3,4'-dimethoxyflavone.
  • A specific compound was identified that effectively suppresses oxacillin resistance in MRSA.
  • Initial investigations into the mechanism of action for the resistance-suppressing compound were initiated.

Conclusions:

  • The flavone scaffold is a promising starting point for developing novel ArlRS inhibitors.
  • Optimized flavone derivatives show potential for combating MRSA infections by targeting virulence and resistance mechanisms.
  • Further research into the identified compounds could lead to new therapeutic agents against challenging MRSA infections.

More Related Videos

Isolation of Lipoprotein Particles from Chicken Egg Yolk for the Study of Bacterial Pathogen Fatty Acid Incorporation into Membrane Phospholipids11:59

Isolation of Lipoprotein Particles from Chicken Egg Yolk for the Study of Bacterial Pathogen Fatty Acid Incorporation into Membrane Phospholipids

Published on: May 15, 2019

9.8K
Improved Enzyme Protection Assay to Study Staphylococcus aureus Internalization and Intracellular Efficacy of Antimicrobial Compounds06:36

Improved Enzyme Protection Assay to Study Staphylococcus aureus Internalization and Intracellular Efficacy of Antimicrobial Compounds

Published on: September 8, 2021

2.8K

Related Concept Videos

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
820
Adrenergic Agonists: Chemistry and Structure-Activity Relationship01:16

Adrenergic Agonists: Chemistry and Structure-Activity Relationship

Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
3.2K
Local Anesthetics: Chemistry and Structure-Activity Relationship01:27

Local Anesthetics: Chemistry and Structure-Activity Relationship

Local anesthetics (LAs) are drugs that induce a temporary loss of sensation in a limited body area, preventing pain. Cocaine was the first local anesthetic discovered in the late 19th century. Cocaine is a benzoic acid ester obtained from the leaves of coca shrubs and was often used for its psychotropic effects. Cocaine was first isolated in 1860 by Albert Niemann. Sigmund Freud studied the physiological actions of cocaine. Carl Koller later introduced it into clinical practice in 1884 as a...
4.5K
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship01:22

Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
1.1K